Minerva Neurosciences, Inc. — Director's Dealing 2017

Feb 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-02-03

Reporting Person: Luthringer Remy (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-03	Common Stock	M	32096	$4.71	Acquired	32096	Direct
2017-02-03	Common Stock	S	32096	$11.02	Disposed	0	Direct
2017-02-06	Common Stock	M	2185	$4.71	Acquired	2185	Direct
2017-02-06	Common Stock	S	2185	$11.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-03	Stock Option (Right to Buy)	$4.71	M	32096	Disposed	2025-12-03	Common Stock (32096)	Direct
2017-02-06	Stock Option (Right to Buy)	$4.71	M	2185	Disposed	2025-12-03	Common Stock (2185)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	926604	Indirect

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

F3: This option shall vest as follows: 25% vested on December 4, 2016 and the remainder vests in quarterly installments over 3 years thereafter.